Food for better living
Flow leads the research, development and commercialization of clinically-proven functional foods
Transforming health outcomes through trusted, clinically-proven functional foods
We combine insights from metabolic science and clinical medicine with the latest food technology to create functional foods that are clinically proven to address specific health needs.
Our team brings together medical professionals, scientists, product developers, and entrepreneurs with experience in biotech, pharmaceuticals, nutrition, investment, and academic research.
Science
Our proven 3-stage process
Flow follows a standard development process to create innovative clinically-proven functional foods.
1
Target
Apply scientific insights to the body’s natural pathways to identify solutions for unmet health needs
2
Build
Design innovative solutions using state-of-the-art food production technologies
3
Prove
Prove effectiveness through meaningful clinical and patient outcomes data
Innovation
A strong pipeline focused on specific
health needs across therapy areas
| Target | Build | Prove | |
|---|---|---|---|
|
FLO23011 (klario): Diabetes
EU launch 2025
|
Target
|
Build
|
Prove
|
|
FLO23017: Cardiovascular Health
launch 2026
|
Target
|
Build
|
Prove
|
|
Future indications
including endocrinology and women's health
|
Target
|
Build
|
Prove
|
Brands
Transforming self-care in diabetes hypoglycaemia
Klario is a novel combination treatment for complete recovery from hypoglycaemia in diabetes, clinically proven to be more effective than standard sugar products.
Better Control: extended time in target blood sugar range post-hypoglycaemia, with 27% fewer recurrences
More Effective: 75% got back to their day faster, with less brain fog and fatigue
Real World Preference: users reported better taste, easier usability and increased confidence in self-management
People
Bringing together deep expertise in
medicine, science and commercial innovation
Leadership
Georgia Myers
CEO
Richard Littlewood, MD
Chairman
Tara Lumley
Chief Strategy & Business Officer
Advisors
Prof. David Russell-Jones
Professor of Professor of Diabetes and Endocrinology at the University of Surrey; an international authority on insulin and diabetes with extensive years experience
Rob Lewis
Expert in healthcare innovation, with 20 years experience launching smart healthcare products and services for consumers and patients
Sebastian Mullin
Board-level leader and strategic advisor with 30+ years experience across healthcare, nutrition and food
Prof. Mike Laffan
Professor of Haemostasis and Thrombosis at Imperial College London with 30+ years clinical, academic and guideline leadership experience
Contact
Get in touch
We’re always seeking passionate partners, investors, and talented people to join our mission. Contact us to learn more